Non-Muscle Invasive Bladder Cancer Latest Advances

Find the Latest Research About Non-Muscle Invasive Bladder Cancer

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 815 publications

Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.

Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.

Journal: The Cochrane database of systematic reviews

Published: June 11, 2026

A Retrospective Follow-up Study on the Effects of Different Intravesical Treatments on Recurrence Control and Quality of Life in Patients With Non-Muscle-Invasive Bladder Cancer After Transurethral Resection of Bladder Tumour.

A Retrospective Follow-up Study on the Effects of Different Intravesical Treatments on Recurrence Control and Quality of Life in Patients With Non-Muscle-Invasive Bladder Cancer After Transurethral Resection of Bladder Tumour.

Journal: Archivos espanoles de urologia

Published: June 10, 2026

Predictors of BCG Therapy Complications in Non-Muscle-Invasive Bladder Cancer: A Clavien-Dindo-Based Study.

Predictors of BCG Therapy Complications in Non-Muscle-Invasive Bladder Cancer: A Clavien-Dindo-Based Study.

Journal: Archivos espanoles de urologia

Published: May 09, 2026

Current Evidence on the Use of Cystoscopy in the Follow-up of Non-Muscle-Invasive Bladder Cancer: Are We Overusing It? Systematic Review of the Literature.

Current Evidence on the Use of Cystoscopy in the Follow-up of Non-Muscle-Invasive Bladder Cancer: Are We Overusing It? Systematic Review of the Literature.

Journal: Archivos espanoles de urologia

Published: May 09, 2026

Expert consensus on intravesical therapy for non-muscle invasive bladder cancer (2025 edition)

Expert consensus on intravesical therapy for non-muscle invasive bladder cancer (2025 edition)

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: May 05, 2026

Factors influencing adherence to intravesical instillation therapies for non-muscle-invasive bladder cancer: a scoping review protocol.

Factors influencing adherence to intravesical instillation therapies for non-muscle-invasive bladder cancer: a scoping review protocol.

Journal: BMJ open

Published: May 05, 2026

Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study.

Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study.

Journal: JCO global oncology

Published: April 29, 2026

Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

Journal: Future oncology (London, England)

Published: April 27, 2026

Addressing the challenges of health economic modelling in the context of suboptimal evidence base - case study based on a comparison between photodynamic diagnosis and narrow band imaging in non-muscle invasive bladder cancer.

Addressing the challenges of health economic modelling in the context of suboptimal evidence base - case study based on a comparison between photodynamic diagnosis and narrow band imaging in non-muscle invasive bladder cancer.

Journal: Journal of medical economics

Published: April 25, 2026

Evolution of survival outcomes in robot-assisted radical cystectomy over 20 years of experience in a high-volume tertiary robotic center.

Evolution of survival outcomes in robot-assisted radical cystectomy over 20 years of experience in a high-volume tertiary robotic center.

Journal: Minerva urology and nephrology

Published: April 23, 2026

Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in people undergoing radical cystectomy.

Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in people undergoing radical cystectomy.

Journal: The Cochrane database of systematic reviews

Published: April 23, 2026

Detrimental effect of delayed or incomplete BCG protocols administration after trans-urethral tumor resection in patients with non-muscle-invasive bladder cancer: a systematic review.

Detrimental effect of delayed or incomplete BCG protocols administration after trans-urethral tumor resection in patients with non-muscle-invasive bladder cancer: a systematic review.

Journal: Minerva urology and nephrology

Published: April 23, 2026

Showing 1-12 of 815

Last Updated: 06/30/2026